Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-05

Clinical Trial Update: Safety and Efficacy Study of BRIMOCHOL™, BRIMOCHOL™ F, and Carbachol in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia [Phase 2]

View source ↗

Summary

A Phase 2 safety and efficacy study of BRIMOCHOL, BRIMOCHOL F, and Carbachol in presbyopia has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BRIMOCHOL
  • BRIMOCHOL F
  • Carbachol (Carbachol)

Snippet

Sponsor: Visus Therapeutics | Conditions: Presbyopia | Phase 2 | Status: COMPLETED | Results posted: 2025-02-05